Sentences with phrase «with big pharma»

They provide excellent experience and open up later opportunities with big pharma or contracting.

Big Agra works with Big Pharma to keep diabeties on the rise as well as our obesity epidemic.

It began with the Flexner Report and continues with Big Pharma.

I'm hoping that with research and support, that I can make this a success and not have to resort to sleeping with big Pharma.

That's the best we can do as the FDA is too bogged down with issues like the dairy industry trying to sneak sugar into milk without labeling it and the constant craziness with Big Pharma — I have friends who do or have worked there, there's no «extra» money for the FDA to go around figuring out exactly what all the compounds in a glass of milk do inside your body.

But what is skipping food got to do with Big Pharma, you would ask?

That all fits closely with the president's insistence — outlined in a recent session with Big Pharma executives — that the drug approval process needs to be deregulated, insisting that slashing FDA rules was needed in order to cut drug prices.

Despite the different focus of biotech research, the links with big pharma are obvious, so any pharmaceutical scientist must be comfortable working across both sectors.

«We don't want to compete with Big Pharma,» Callahan says.

«We are in direct competition with big pharma.»

The article was a no - holds - barred denunciation of the U.S. public - health establishment, purporting to tell the story of how «government health agencies colluded with Big Pharma to hide the risks of thimerosal from the public... a chilling case study of institutional arrogance, power, and greed.»

IN TODAY»S biotech industry, start - up companies sprout from every university biology department, looking to hook up with big pharma or agrochemical firms to take their patented, DNA - based ingenuity lucratively to market.

Our government is corrupt, along with big pharma, ins cos and the medical field.

And given the minimal cost of Cytotec, I'm really not impressed with the Big Pharma conspiracy angle.

Modern psychiatry, in league with Big Pharma, has devolved almost purely into prescribing medication for pseudo-medical illness, giving pills instead of compassion, and thus trivializing human suffering.

Trump meets with big pharma CEOs and issues a list of demands.

«There are two ways to receive validation: from partnerships with big pharma and from smart investors,» Bloom says.

Not exact matches

Big pharma's return on investment vis - a-vis R&D plummeted to a dismal 3.2 % in 2017 compared with 10.1 % in 2010.

Big biotech and pharma companies are absolutely dependent on being able to successfully innovate by partnering with and acquiring disruptive startups because of the nature of the patent cliff in pharmaceuticals.

Reuters is out with a big piece on the big changes planned at U.K. pharma giant GlaxoSmithKline under new CEO Emma Walmsley — including substantial budget demands.

She speculates that the company strengthened its bonds with customers by taking a stand against Big Pharma.

In the last few years, the number of clinical trials in this field has exploded, along with the flurry of money from Big Pharma and investors, stirring optimism in the fight against cancer.

For one, big pharma's supply chain is a global enterprise with global ambitions, and manufacturing is cheaper in countries like India and China.

The report points to a number of factors driving big pharma companies» struggles with netting strong returns, including a dearth of late - stage pipeline candidates and diversified product portfolios that aren't necessarily spreading risk.

He wasn't surprised that startup CEOs spoke up while the major players did not: «There are a lot more ways for the Trump administration to hurt Big Pharma firms with products on the market than there are ways for the Trump administration to hurt biotech firms.»

Specialty pharmacies — pharmacies that act as a separate distribution and billing mechanism for big drug firms — aren't unheard of in the world of big pharma, but Valeant's relationship with Philidor was strangely close.

As an exec at Shire (shpg), which with $ 6 billion in revenue is one of the smaller Big Pharmas, he spent months persuading leaders and commercial and supply - chain people to launch a clinical trial for the ADHD drug Vyvanse to treat binge eating.

People object to a system that they see as being dominated by big pharma, a system that intrusively asserts control over our lives, telling us what's wrong with us, and telling us what we must do in order to get better (as they choose to define «better»).

The intense, full - day strategy sessions invariably ended with Cornelius getting a headache, he says — particularly when he sparred with executives in the company who clung to vestiges of big, fat pharma.

Concerns over these patent expiries, coupled with the recession, caused many investors to flee Big Pharma stocks altogether.

But the serial acquirers that defined the last decade of specialty pharma dealmaking — Teva Pharmaceuticals, Valeant Pharmaceuticals, and Endo International — are no longer in the position to take on bigger deals, as they're all saddled with too much debt.

Immuno - oncolocy has been the focus of Big Pharma and biotechs alike, with companies such as Merck (mrk), Bristol - Myers Squibb (bmy), Pfizer (pfe), Roche / Genentech, Juno (juno), Kite Pharma (kite), Novartis (nvs), and countless others pouring massive investments into the space (the Loncar ETF contains almost all of these companies).

The race to become the first company with a chimeric antigen receptor T - cell (CAR - T) cancer therapy on the market has entered its final leg, and Kite Pharma now appears to have a big advantage.

But Apple and other Big Tech corporations like Google and Amazon — along with much of Big Pharma and even Starbucks — have avoided paying hundreds of billions of dollars in taxes on their worldwide earnings because they don't mainly sell physical things like cars or refrigerators or television sets that they make here and ship abroad.

And big players like J&J have been successful in stalling the competition through a framework of deals with the companies managing pharma benefits in the US.

Rachel Thompson graduated from California State University, with a degree in Communications Studies and spent 17 years working in Big Pharma.

With two of its top four holdings having at least doubled so far in 2015, the usual big - pharma names won't be as important to the SPDR Pharmaceuticals ETF's future performance as they are for most similar sector ETFs.

IMHO, big pharma / food industry (e.g., dry baby milk producers, charging $ 50 / can) colluded with the fake Jesus - freaks to make breastfeeding in public a moral issue.

(See: Study: Saturated Fat Not Associated with Risk of Coronary Artery Disease, Coconut Oil and Dairy Fat Healthy and Big Pharma Study: USDA Dietary Guidelines on Fats are Wrong.)

Some might say I'm letting Big Pharma play roulette with my kid's brain chemistry, and maybe that's true.

Not sure if that's not in vogue with the all natural crowd, but I don't see anyone complaining when their chiropractor sells them priobiotics for 40 $ a jar, so I am failing to see how giving enfamil 15 bucks for 2 months worth of polyvisol is some big pharma scam.

«Big pharma keeps coming up with excuses to skirt responsibility for the opioid crisis that they created,» said budget spokesman Morris Peters.

Scott pivoted slightly, thinking that working in Big Pharma might be more in tune with her nature.

In the case of vaccines, that emotional response probably stems from many things, Mnookin says, including frustration with our lack of personalized health care, a general distrust of large corporations and of big pharma specifically, distrust that isn't necessarily misplaced.

She participated in collaborations with small biotech companies and big pharma.

«Big pharma has been fairly resilient, with pharmaceutical firms continuing to hire for drug development.

Try to talk with some people working in the industry, perhaps some old university colleagues who are now working in big pharma.

That's important because too often bacterial mutations engender resistance to treatment, rendering many drugs ineffective and outpacing Big Pharma's efforts to come up with alternative drugs.

Enoch Huang, head of computational sciences at Pfizer PharmaTherapeutics Research and Development in Cambridge, Massachusetts, says that big pharma needs scientists with computational biology skills right now, but the needs are precise.

As the pharmaceutical industry's blockbuster drugs fall off the patent cliff, with precious few drugs in the pipeline to replace them, there are signs that big pharma could turn more of its attention to biologically derived medicines.